Wednesday, April 27, 2016

UPDATE 1-Samsung Biologics plans IPO this year, seen worth as much as $2.6 bln

* Aims to be the world's largest contract manufacturer

(Adds company details, biotech market background)

Read more

No comments:

Post a Comment